(ONTY:Consolidated Issue Listed on NASDAQ Global Select )
Robert L. Kirkman M.D.
Chief Executive Officer, President and Director,Oncothyreon Inc
|Age||Total Calculated Compensation||This person is connected to 13 board members in 2 different organizations across 4 different industries.|
See Board Relationships
As of Fiscal Year 2014
Dr. Robert L. Kirkman, MD has been the Chief Executive Officer and President of Oncothyreon Inc. (alternate name Biomira Inc) since September 5, 2006. Dr. Kirkman served as an Acting President and Acting Chief Executive Officer at Xcyte Therapies Inc., from July 2005 to 2006. He served as Chief Business Officer and Vice President of Xcyte Therapies Inc., from February 16, 2004 to July 2005. He served as Chief Executive Officer of Xcyte Therapies Inc. He served as Chief ...
2601 Fourth AvenuePhone: 206-801-2100
Seattle, Washington 98121
Board Members Memberships*
Chief Executive Officer, President and Director
Independent Director, Member of Audit Committee and Member of Compensation Committee
Harvard Medical School
|There is no Competitor Compensation data available.|